Emeprev™ (maropitant citrate) Injectable Solution is the first FDA-approved bioequivalent injectable solution to the most widely used antiemetic for dogs and cats. Emeprev™ will deliver the same trusted antiemetic effectiveness as the pioneer but with a differentiated preservative for comfort. The product requires no refrigeration, according to the company.
Source: Dechra, December 8, 2025. Link. The product will be available for order through all major veterinary distributors in early 2026.